- Last edited on February 9, 2022
Differences
This shows you the differences between two versions of the page.
geri:dementia:corticobasal-degeneration-cbd [on June 2, 2019] |
geri:dementia:corticobasal-degeneration-cbd [on June 2, 2019] |
||
---|---|---|---|
Line 2: | Line 2: | ||
{{INLINETOC}} | {{INLINETOC}} | ||
===== Primer ===== | ===== Primer ===== | ||
- | **Corticobasal Degeneration** (CBD) is an neurodegenerative disorder, classified as an atypical parkinsonian syndrome (also known as Parkinson's Plus). CBD was previously classified as a progressive asymmetric movement disorder characterized by akinesia, rigidity, dystonia, focal myoclonus, ideomotor apraxia, and/or alien-limb phenomena. However, it is increasingly seen as a disorder with cognitive and behavioural disturbances as well. The diagnosis of CBD remain challenging because there is considerable overlap between CBD pathology and other neurodegenerative disorders (including [[geri:dementia:progressive-supranuclear-palsy-psp|progressive supranuclear palsy]] (PSP), [[geri:dementia:alzheimers|]], and [[geri:dementia:frontotemporal|frontotemporal dementia]]). | + | **Corticobasal Degeneration** (CBD) is an neurodegenerative disorder, classified as an atypical parkinsonian syndrome (also known as one of the Parkinson's-plus syndromes). CBD was previously classified as a progressive asymmetric movement disorder characterized by akinesia, rigidity, dystonia, focal myoclonus, ideomotor apraxia, and/or alien-limb phenomena. However, it is increasingly seen as a disorder with cognitive and behavioural disturbances as well. The diagnosis of CBD remain challenging because there is considerable overlap between CBD pathology and other neurodegenerative disorders (including [[geri:dementia:progressive-supranuclear-palsy-psp|progressive supranuclear palsy]] (PSP), [[geri:dementia:alzheimers|]], and [[geri:dementia:frontotemporal|frontotemporal dementia]]). |
===== Diagnostic Criteria ===== | ===== Diagnostic Criteria ===== |